Novel nanocrystal formulation of megestrol acetate has improved bioavailability compared with the conventional micronized formulation in the fasting state

BACKGROUND: Megestrol acetate is an effective treatment for improving appetite and increasing body weight in patients with cancer-associated anorexia. However, Megace(®) oral suspension (OS), a micronized formulation of megestrol acetate, has low bioavailability in the fasting state. To overcome thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Jang, Kyungho, Yoon, Seonghae, Kim, Sung-Eun, Cho, Joo-Youn, Yoon, Seo Hyun, Lim, Kyoung Soo, Yu, Kyung-Sang, Jang, In-Jin, Lee, Howard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4077389/
https://www.ncbi.nlm.nih.gov/pubmed/25028536
http://dx.doi.org/10.2147/DDDT.S62176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4077389/
https://www.ncbi.nlm.nih.gov/pubmed/25028536
http://dx.doi.org/10.2147/DDDT.S62176

Ejemplares similares